TB-Related Articles

2017 DTBE Publications

Agizew T, Basotli J, Alexander H, Boyd R, Letsibogo G, Auld A, Nyirenda S, Tedla Z, Mathoma A, Mathebula U, Pals S, Date A, Finlay A. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.external icon PLoS One. 2017 Dec 22;12(12):e0189981. doi: 10.1371/journal.pone.0189981. eCollection 2017. PMID: 29272273.

Agizew T, Boyd R, Ndwapi N, Auld A, Basotli J, Nyirenda S, Tedla Z, Mathoma A, Mathebula U, Lesedi C, Pals S, Date A, Alexander H, Kuebrich T, Finlay A. Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswanaexternal icon. PLoS One. 2017 Aug 17;12(8):e0183237. doi: 10.1371/journal.pone.0183237. eCollection 2017. PMID: 28817643..

Alsultan A, Savic R, Dooley KE, Weiner M, Whitworth W, Mac Kenzie WR, Peloquin CA; Tuberculosis Trials Consortium. Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.external icon Antimicrob Agents Chemother. 2017 Mar 13. pii: AAC.02625-16. doi: 10.1128/AAC.02625-16. [Epub ahead of print]. PMID: 28289033.

Badal-Faesen S, Firnhaber C, Kendall MA, Wu X, Grinsztejn B, Escada RODS, Fernandez M, Hogg E, Sanne I, Johnson P, Alland D, Mazurek GH, Benator DA, Luetkemeyer AF; AIDS Clinical Trials Group A5295; Tuberculosis Trials Consortium Study 34 Teams. Impact of Larger Sputum Volume on Xpert^® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.external icon J Clin Med. 2017 Aug 7;6(8). pii: E78. doi: 10.3390/jcm6080078. PMID: 28783093

Barry PM, Lowenthal P, True L, Henry L, Schack G, Wendorf K, Flood J, Shah N. Benefit of the Shorter MDR TB Treatment Regimen in California and Modified Eligibility Criteria.external icon Am J Respir Crit Care. 2017 Dec 1;196(11):1488-1489. doi: 10.1164/rccm.201701-0013LE. PMID: 28665681.

Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS; TB Trials Consortium iAdhere Study Team. Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.external icon Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7. PMID: 29114781.

Boyd R, Ford N, Padgen P, Cox H. Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.external icon Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1173-1180. doi: 10.5588/ijtld.17.0230. PMID: 29037299.

Breedlove B, Chorba T. Elaborate details, hidden surprises. Emerg Infect Dis 2017; 23:1229–30.

Castro KG, Marks SM, Hill AN, Chen MP, Miramontes R, Winston CA, LoBue PA. In reply.external icon Int J Tuberc Lung Dis. 2017 Jan 1;21(1):120-121. doi: 10.5588/ijtld.16.0708-2. No abstract available. PMID: 28157476.

Cavanaugh JS, Jou R, Wu MH, Dalton T, Kurbatova E, Ershova J, Cegielski JP; Global PETTS Investigators. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.external icon J Antimicrob Chemother. 2017 Jun 1;72(6):1678-1687. doi: 10.1093/jac/dkx022. PMID: 28333192.

CDC (Olano-Soler H, Thomas, D, Joglar O, Rios K, Torres-Rodríguez M, Duran-Guzman G,   Chorba T). Notes from the Field: Use of Asynchronous Video Directly Observed Therapy for Treatment of Tuberculosis and Latent Tuberculosis Infection in a Long-Term-Care Facility – Puerto Rico, 2016-2017.external icon MMWR 2017 Dec 22;66(50):1386–1387. doi: 10.15585/mmwr.mm6650a5.

CDC (Morris S, Miner M, Rodriguez T, Stancil, R, Wiltz-Beckham D, Chorba T). Notes from the Field: Tuberculosis Control Activities After Hurricane Harvey — Texas, 2017. Weekly 2017 December 15;66(49);1362–1363.

CDC (Schmit KM, Wansaula Z, Pratt R, Price SF, Langer, AJ). Tuberculosis — United States, 2016. MMWR 2017 March 24; 66(11);289–294. doi: http://dx.doi.org/10.15585/mmwr.mm6611a2external icon.

CDC (Tsang CA, Langer AJ, Navin TR, Armstrong, LR).Tuberculosis Among Foreign-Born Persons Diagnosed ≥10 Years After Arrival in the United States, 2010–2015. MMWR 2017 March 24; 66(11);295–298. doi: http://dx.doi.org/10.15585/mmwr.mm6611a3external icon.

Chorba T, Jereb J. Keeping It in the Family: the Childhood Burden of Tuberculosisexternal icon. Emerging Infectious Diseases. 2017 Mar;23(3):561-562. doi:10.3201/eid2303.AC2303.

Garzan A, Willby MJ, Ngo HX, Gajadeera CS, Green KD, Holbrook SYL, Hou C, Posey JE, Tsodikov OV, Garneau-Tsodikova S. Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors. ACS Infect Dis.external icon 2017 Apr 14;3(4):302-309. doi: 10.1021/acsinfecdis.6b00193. Epub 2017 Feb 17. PMID: 28192916.

Hall EW, Morris SB, Moore BK, Erasmus L, Odendaal R, Menzies H, van der Walt M, Smith SE. Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.external icon Pediatr Infect Dis J. 2017 Dec;36(12):e322-e327. doi: 10.1097/INF.0000000000001691. PMID: 28746263.

Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013.external icon Public Health Rep. 2017 May/Jun;132(3):366-375. doi: 10.1177/0033354917698117. Epub 2017 Apr 10. PMID: 28394707.

Jeffries C, Lobue P, Chorba T, Metchock B, Kashef I. Role of the Health Department in Tuberculosis Prevention and Control-Legal and Public Health Considerations.external icon Microbiol Spectr. 2017 Mar;5(2). doi: 10.1128/microbiolspec.TNMI7-0034-2016. PMID: 28256190.

Jones JM, Armstrong LR. Delayed and Unreported Drug-Susceptibility Testing Results in the US National Tuberculosis Surveillance System, 1993-2014.external icon Public Health Rep. 2017 Jul/Aug;132(4):480-487. doi: 10.1177/0033354917708989. Epub 2017 Jun 6. PMID: 28586626.

Kay A, Barry PM, Annambhotla P, Greene C, Cilnis M, Chin-Hong P, Arger N, McNitt L, Neidlinger N, Shah N, Basavaraju SV, Kuehnert M, Shaw T. Solid Organ Transplant-Transmitted Tuberculosis Linked to a Community Outbreak – California, 2015.external icon MMWR Morb Mortal Wkly Rep. 2017 Aug 4;66(30):801-805. doi: 10.15585/mmwr.mm6630a1. PMID: 28771459.

Khan AD, Dean HD. Tuberculosis among adults and the determinants of health [Internet]. Oxford Bibliographies 2017; http://www.oxfordbibliographies.com/view/document/obo-9780199756797/obo-9780199756797-0170.xmlexternal icon. doi: 10.1093/obo/9780199756797-0170. 

Lempp JM, Zajdowicz MJ, Hankinson AL, Toney SR, Keep LW, Mancuso JD, Mazurek GH. Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.external icon PLoS One. 2017 May 17;12(5):e0177752. doi: 10.1371/journal.pone.0177752. eCollection 2017. PMID: 28545136.

Levanon Seligson A, Parvez FM, Lim S, Singh T, Mavinkurve M, Harris TG, Kerker BD. Public Health and Vulnerable Populations: Morbidity and Mortality Among People Ever Incarcerated in New York City Jails, 2001 to 2005.external icon J Correct Health Care. 2017 Oct;23(4):421-436. doi: 10.1177/1078345817727527. Epub 2017 Oct 5. PMID: 28982284.

Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O’Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.external icon Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778. PMID: 28052967.

LoBue PA, Mermin JH. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.external icon Lancet Infect Dis. 2017 Oct;17(10):e327-e333. doi: 10.1016/S1473-3099(17)30248-7. Epub 2017 May 8. PMID: 28495525.

Macaraig M, Lobato MN, McGinnis Pilote K, Wegener D. A National Survey on the Use of Electronic Directly Observed Therapy for Treatment of Tuberculosis.external icon J Public Health Manag Pract. 2017 Jul 7. doi: 10.1097/PHH.0000000000000627. PMID: 28692611.

Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review.external icon PLoS One. 2017 Aug 7;12(8):e0180707. doi: 10.1371/journal.pone.0180707. eCollection 2017. PMID: 28786991.

Marks SM, Hirsch-Moverman Y, Seaworth B, Salcedo K, Graviss EA, Armstrong L, Armitige L, Flood J, Mase S. Outcomes and costs of out-patient MDR-TB care in the USA.external icon Int J Tuberc Lung Dis. 2017 Apr 1;21(4):477-478. doi: 10.5588/ijtld.17.0009. No abstract available. PMID: 28284273.

Marks SM, Mase SR, Bamrah Morris S. Systematic Review, Meta-Analysis, and Cost Effectiveness of Treatment of Latent Tuberculosis Infection to Reduce Progression to Multidrug-Resistant Tuberculosis.external icon Clin Infect Dis. 2017 Jun 15;64(12):1670-1677. doi: 10.1093/cid/cix208. PMID: 28329197.

Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, Rustomjee R, Silk BJ, Wood R. Drivers of Tuberculosis Transmission.external icon J Infect Dis. 2017 Nov 3;216(suppl_6):S644-S653. doi: 10.1093/infdis/jix354. PMID: 29112745.

McDaniel CJ, Chitnis AS, Barry PM, Shah N. Tuberculosis trends in California correctional facilities, 1993-2013.external icon Int J Tuberc Lung Dis. 2017 Aug 1;21(8):922-929. doi: 10.5588/ijtld.16.0855. PMID: 28786801.

Mindra G, Wortham JM, Haddad MB, Powell KM. Tuberculosis Outbreaks in the United States, 2009-2015.external icon Public Health Rep. 2017 Mar/Apr;132(2):157-163. doi: 10.1177/0033354916688270. Epub 2017 Feb 1. PMID: 28147211.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC. A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>.external icon Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec. PMID: 29284687.

Morlock GP, Tyrrell FC, Baynham D, Escuyer VE, Green N, Kim Y, Longley-Olson PA, Parrish N, Pennington C, Tan D, Austin B, Posey JE. Using reduced inoculum densities of Mycobacterium tuberculosis in MGIT pyrazinamide susceptibility testing to prevent false-resistant results and improve accuracy: a multi-center evaluation. Tuberc Res Treat.external icon 2017;2017:3748163. doi: 10.1155/2017/3748163. Epub 2017 Nov 8. PMID: 29250443.

Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S. Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. Int J Tuberc Lung Dis.external icon 2017 Mar 1;21(3):286-296. doi: 10.5588/ijtld.16.0469. PMID: 28087928.

Owusu-Edusei K, Marks SM, Miramontes R, Stockbridge EL, Winston CA. Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.external icon Int J Tuberc Lung Dis. 2017 Apr 1;21(4):398-404. doi: 10.5588/ijtld.16.0587. PMID: 28284254.

Owusu-Edusei K, Stockbridge EL, Winston CA, Kolasa M, Miramontes R. Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States.external icon Int J Tuberc Lung Dis. 2017 Mar 28. doi: 10.5588/ijtld.16.0617. [Epub ahead of print]. PMID: 28351463.

Owusu-Edusei Jr. K, Winston CA, Marks SM, Langer AJ, Miramontes R. Tuberculosis Test Usage and Medical Expenditures from Outpatient Insurance Claims Data, 2013.external icon Tuberc Res Treat. 2017;2017:3816432. doi: 10.1155/2017/3816432. Epub 2017 Oct 23. PMID: 29326845.

Parmer J, Allen L, Walton W. CE: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States.external icon Am J Nurs. 2017 Jul 12. doi: 10.1097/01.NAJ.0000521946.45448.90. [Epub ahead of print]. PMID: 28704234.

Powell KM, VanderEnde DS, Holland DP, Haddad MB, Yarn B, Yamin AS, Mohamed O, Sales RF, DiMiceli LE, Burns-Grant G, Reaves EJ, Gardner TJ, Ray SM. Outbreak of Drug-Resistant Mycobacterium tuberculosis Among Homeless People in Atlanta, Georgia, 2008-2015.external icon Public Health Rep. 2017 Mar/Apr;132(2):231-240. doi: 10.1177/0033354917694008. PMID: 28257261.

Reaves EJ, Shah NS, France AM, Morris SB, Kammerer S, Skarbinski J, Bradley H. Latent tuberculous infection testing among HIV-infected persons in clinical care, United States, 2010-2012.external icon Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1118-1126. doi: 10.5588/ijtld.17.0041. PMID: 28911355.

Salinas JL, Armstrong LR, Silk BJ, Haddad MB, Cegielski JP. Factors Associated with All-Cause Mortality among Patients with Multidrug-Resistant Tuberculosis – United States, 1993-2013.external icon Clin Infect Dis. 2017 Jul 29. doi: 10.1093/cid/cix667. [Epub ahead of print.] PMID: 29020169.

Sandul AL, Nwana N, Holcombe JM, Lobato MN, Marks S, Webb R, Wang SH, Stewart B, Griffin P, Hunt G, Shah N, Marco A, Patil N, Mukasa L, Moro RN, Jereb J, Mase S, Chorba T, Bamrah-Morris S, Ho CS. High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection.external icon Clin Infect Dis. 2017 May 30. doi: 10.1093/cid/cix505. [Epub ahead of print]. PMID: 28575208.

Savic RM, Weiner M, MacKenzie WR, Engle M, Whitworth WC, Johnson JL, Nsubuga P, Nahid P, Nguyen NV, Peloquin CA, Dooley KE, Dorman SE; Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.external icon Clin Pharmacol Ther. 2017 Aug;102(2):321-331. doi: 10.1002/cpt.634. Epub 2017 Mar 2. PMID: 28124478.

Scott C, Cavanaugh JS, Silk BJ, Ershova J, Mazurek GH, LoBue PA, Moonan PK. Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.external icon Emerg Infect Dis. 2017 Mar;23(3):456-462. doi: 10.3201/eid2303.161916. PMID: 28221125.

Scott C, Mangan J, Tillova Z, Jensen PA, Ahmedov S, Ismoilova J, Trusov A. Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.external icon Int J Tuberc Lung Dis. 2017 May 1;21(5):579-585. doi: 10.5588/ijtld.16.0518. PMID: 28399974.

Shah NS, Flood-Bryzman A, Jeffries C, Scott J. Towards a Generation Free of Tuberculosis: TB disease and Infection in Individuals of College Age in the United States.external icon J Am Coll Health. 2018 Jan;66(1):17-22. doi: 10.1080/07448481.2017.1363765. Epub 2017 Sep 15. PMID: 28800282.

Sharma A, Hill A, Kurbatova E, van der Walt M, Kvasnovsky C, Tupasi TE, Caoili JC, Gler MT, Volchenkov GV, Kazennyy BY, Demikhova OV, Bayona J, Contreras C, Yagui M, Leimane V, Cho SN, Kim HJ, Kliiman K, Akksilp S, Jou R, Ershova J, Dalton T, Cegielski P; Global Preserving Effective TB Treatment Study Investigators. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.external icon Lancet Infect Dis. 2017 May 9. pii: S1473-3099(17)30247-5. doi: 10.1016/S1473-3099(17)30247-5. [Epub ahead of print]. PMID: 28499828.

Shin SS, Modongo C, Boyd R, Caiphus C, Kuate L, Kgwaadira B, Zetola NM. High Treatment Success Rates Among HIV-Infected Multidrug-Resistant Tuberculosis Patients After Expansion of Antiretroviral Therapy in Botswana, 2006-2013.external icon J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):65-71. PMID: 27552155.

Shrestha S, Hill AN, Marks SM, Dowdy DW. Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas.external icon Am J Respir Crit Care Med. 2017 May 5. doi: 10.1164/rccm.201702-0377OC. [Epub ahead of print]. PMID: 28475845.

Sigal GB, Segal MR, Mathew A, Jarlsberg L, Wang M, Barbero S, Small N, Haynesworth K, Davis JL, Weiner M, Whitworth WC, Jacobs J, Schorey J, Lewinsohn DM, Nahid P. Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.external icon EBioMedicine. 2017 Oct 24. pii: S2352-3964(17)30417-6. doi: 10.1016/j.ebiom.2017.10.018. [Epub ahead of print]. PMID: 29100778.

Sinha SK, Saxena A, Mishra V, Volkmann T, Kumar AMV, Nair SA, Moonan PK, Oeltmann JE, Chadha VK. Integration and decentralisation of TB-HIV services increases HIV testing of TB cases in Rajasthan, India.external icon Public Health Action. 2017 Mar 21;7(1):71-73. doi: 10.5588/pha.16.0060. PMID: 28775947.

Smith SE, Pratt R, Trieu L, Barry PM, Thai DT, Ahuja SD, Shah S. Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014.external icon Clin Infect Dis. 2017 Jun 19. doi: 10.1093/cid/cix561. [Epub ahead of print]. PMID: 28633501.

Stafford C, Atkinson-Dunn R, Buss SN, Dalton T, Gibson D, Johnston S, King E, Grace Lin SY, Mitchell KK, Murtaugh WA, Sease H, Southern TR, Tans-Kersten JL, Travanty EA, Triplett LR, Wroblewski K, Starks AM. The Use of a Shared Services Model for Mycobacteriology Testing: Lessons Learned.external icon Public Health Rep. 2017 Jan 1:33354917743498. doi: 10.1177/0033354917743498. [Epub ahead of print]. PMID: 29258383.

Stockbridge EL, Miller TL, Carlson EK, Ho C. Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured.external icon J Public Health Manag Pract. 2017 Oct 27. doi: 10.1097/PHH.0000000000000628. [Epub ahead of print]. PMID: 29084120.

Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR Jr, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.external icon JAMA Intern Med. 2017 Oct 16. doi: 10.1001/jamainternmed.2017.3941. [Epub ahead of print]. PMID: 29049814.

Teeter LD, Kammerer JS, Ghosh S, Nguyen DTM, Vempaty P, Tapia J, Miramontes R, Cronin WA, Graviss EA; Tuberculosis Epidemiologic Studies Consortium. Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006-2010.external icon Tuberculosis (Edinb). 2017 Sep;106:9-15. doi: 10.1016/j.tube.2017.05.003. Epub 2017 May 25. PMID: 28802410.

Thai LH, Nhat L M, Shah N, Lyss S, Ackers M. Sensitivity, completeness and agreement of the tuberculosis electronic system in Ho Chi Minh City, Viet Nam. Public Health Action.external icon 2017 Dec 21;7(4):294-298. doi: 10.5588/pha.17.0081. PMID: 29584795.

Tsang CA, Langer AJ, Navin TR, Armstrong LR. Tuberculosis Among Foreign-Born Persons Diagnosed ≥10 Years After Arrival in the United States, 2010-2015.external icon Am J Transplant. 2017 May;17(5):1414-1417. doi: 10.1111/ajt.14300. PMID: 28453231.

Tupasi T, Garfin AM, Mangan JM, Orillaza-Chi R, Naval LC, Balane GI, Basilio R, Golubkov A, Joson ES, Lew WJ, Lofranco V, Mantala M, Pancho S, Sarol JN, Blumberg A, Burt D, Kurbatova EV. Multidrug-resistant tuberculosis patients’ views of interventions to reduce treatment loss to follow-up.external icon Int J Tuberc Lung Dis. 2017 Jan 1;21(1):23-31. doi: 10.5588/ijtld.16.0433. PMID: 28157461.

Volkmann T, Nguyen B, Anyalechi EG, Chapman Hedges KN, Van Anh H, Tue PQ, Nhung NV, Click ES. Comparison of HIV Testing among Children and Adults with Tuberculosis, Vietnam.external icon J Tuberc Res. 2017 Dec;5(4):292-297. doi: 10.4236/jtr.2017.54030. Epub 2017 Dec 29. PMID: 29349098.

Willby MJ, Wijkander M, Havumaki J, Johnson K, Werngren J, Hoffner S, Denkinger CM, Posey JE. Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO Genoscholar™⋅PZA-TB II as compared to conventional sequencing. Antimicrob Agents Chemother.external icon 2017 Oct 30. pii: AAC.01871-17. doi: 10.1128/AAC.01871-17. [Epub ahead of print]. PMID: 29084743.

Winston CA, Stone ND. Detect to Prevent: Evaluating Testing and Treatment Practices for Latent Tuberculosis Infection in Long-Term Care Facilities.external icon J Am Geriatr Soc. 2017 Mar 17. doi: 10.1111/jgs.14752. [Epub ahead of print]. No abstract available. PMID: 28306136.

Worrell MC, Kramer M, Yamin A, Ray SM, Goswami ND. Use of Activity Space in a Tuberculosis Outbreak: Bringing Homeless Persons Into Spatial Analyses.external icon Open Forum Infect Dis. 2017 Jan 9;4(1):ofw280. doi: 10.1093/ofid/ofw280. eCollection 2017 Winter. PMID: 28480272.

Wortham JM, Goggin M, Mora C, Vandehey L, Manangan L, Powell KM. Acute kidney injury during treatment for latent tuberculous infection with rifampin.external icon Int J Tuberc Lung Dis. 2017 May 1;21(5):596-597. doi: 10.5588/ijtld.17.0003. PMID: 28399977.

 

Last updated March 5, 2018